Uganda follows the example of 17 other African countries that have integrated malaria vaccines into their routine childhood immunisation programmes. These countries represent roughly 70 percent of the ...

Researchers have found a new class of antibodies to treat malaria, paving the way for new malarial prevention strategies. The discovery comes at a time when malaria is still a significant global ...

Shionogi will receive $375 million to develop a long-acting protease inhibitor designed to prevent SARS-CoV-2 infection in ...

Dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine combined with amodiaquine reduced malaria incidence by 94% and ...

Promising new drugs to prevent and treat HIV have the potential to transform the response to the disease. But getting these drugs to those who need it most will be critical, says Beatriz Grinsztejn, ...

WASHINGTON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharmaceuticals” or the “Company”), a pharmaceutical company focused on developing new ...

Tafenoquine is currently FDA-approved for malaria prophylaxis but is not yet approved ... which raises concerns about the potential efficacy of the drug in this context. The mention of substantial ...

This study aims to examine the appropriate utilization of medications for stress ulcer prophylaxis (SUP) and identify factors that contribute to the inappropriate use of these medications in the ICU ...

With malaria being one of the most significant causes of morbidity and mortality worldwide, prompt and effective treatment is essential to reduce the malaria burden. As there are several treatment ...

NIH researchers discovered new antibodies targeting a malaria parasite region not addressed by current vaccines. The most potent, MAD21-101, shows promise for prevention without compromising vaccine ...

Ibuprofen (Advil or Motrin), naproxen (Aleve) and aspirin (Bayer or Ecotrin) are common pain relievers that belong to a class of medication called non-steroidal anti-inflammatory drugs (NSAIDs).

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria. A novel class of antibodies that binds to ...